The Global Biologics Safety Testing Market has been estimated to reach a value of USD 3.0 billion in 2021 and is projected to grow at a CAGR of 12.3% during the forecast period from 2021-2030. The present COVID-19 pandemic situation is further increasing vaccine testing and trials to develop corona vaccines. Government initiatives and vaccine production for the same will, therefore, drive the market.